Skip to main content

Table 2 Comparison between asthmatics and control regarding demographic and laboratory data

From: Vitamin D and cathelicidin assessment in infection-induced asthma in Egyptian children

Variable Healthy control
(group 1)
Patients in remission
(group 2)
Patients in excerption
(group 3)
p value
(between groups)
Age 8.8 ± 2.2 9.3 ± 2.4 9.2 ± 2.3 0.7
Sex males/females 15/20 19/13 21/11 0.8
Weight (kg) 31.2 ± 11.1 30.6 ± 9.6 31.9 ± 12.7 0.9
Height (cm) 130.7 ± 11.2 125.7 ± 9.8 129.2 ± 9.7 0.2
BMI (kg/m2) 17.7 ± 3.4 19.2 ± 5 18.5 ± 4.9 0.5
HB (gm/dl) 12.9 ± 1.6 12.7 ± 1.02 12.6 ± 0.9 0.9
RBCs (cells/mm3) 4.70 4.76 4.73 0.63
WBCs (cells/mm3) 5.8 ± 1.5 7.5 ± 2.5*
(p = 0.03)
8.9 ± 4.2**
(p = 0.001)
0.001
AEC (cells/mm3) 207.8 ± 119.1 340.1 ± 312.3 389.7 ± 347**
(p = 0.01)
0.04
Vitamin D (ng/ml) 10.77 ± 5.6 9.8 ± 4.89 8.49 ± 5 0.29
Serum cathelicidin (ng/ml) 7.69 ± 4.3 6.88 ± 3.66 9.78 ± 3.03***
(p = 0.01)
0.03
  1. BMI body mass index, AEC absolute eosinophilic count
  2. *Comparing healthy controls with patients in remission (groups 1 and 2)
  3. **Comparing healthy controls with patients in exacerbation (groups 1 and 3)
  4. ***Comparing patients in remission with patients in exacerbation (groups 2 and 3)